Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
03 10 2019
Historique:
received: 28 01 2019
revised: 27 05 2019
accepted: 10 07 2019
pubmed: 2 9 2019
medline: 20 2 2020
entrez: 2 9 2019
Statut: ppublish

Résumé

Proteasomes are essential in all eukaryotic cells. However, their function and regulation remain considerably elusive, particularly those of less abundant variants. We demonstrate the human 20S proteasome recombinant assembly and confirmed the recombinant complex integrity biochemically and with a 2.6 Å resolution cryo-EM map. To assess its competence to form higher-order assemblies, we prepared and analyzed recombinant human 20S-PA200, a poorly characterized nuclear complex. Its 3.0 Å resolution cryo-EM structure reveals the PA200 unique architecture; the details of its intricate interactions with the proteasome, resulting in unparalleled proteasome α ring rearrangements; and the molecular basis for PA200 allosteric modulation of the proteasome active sites. Non-protein cryo-EM densities could be assigned to PA200-bound inositol phosphates, and we speculate regarding their functional role. Here we open extensive opportunities to study the fundamental properties of the diverse and distinct eukaryotic proteasome variants and to improve proteasome targeting under different therapeutic conditions.

Identifiants

pubmed: 31473102
pii: S1097-2765(19)30544-1
doi: 10.1016/j.molcel.2019.07.014
pmc: PMC6863390
pii:
doi:

Substances chimiques

Inositol Phosphates 0
Nuclear Proteins 0
Recombinant Proteins 0
proteasome activator 200 kDa, human 0
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138-147.e5

Subventions

Organisme : Medical Research Council
ID : MC_UP_1201/5
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Nature. 1997 Dec 11;390(6660):639-43
pubmed: 9403698
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16165-70
pubmed: 18845680
Mol Cell. 2013 Jul 11;51(1):57-67
pubmed: 23791785
Nature. 2016 Feb 11;530(7589):233-6
pubmed: 26863983
EMBO J. 2002 Jun 3;21(11):2636-45
pubmed: 12032076
Nat Commun. 2017 May 25;8:15578
pubmed: 28541292
Mol Cell. 2005 May 27;18(5):589-99
pubmed: 15916965
Nat Struct Biol. 2000 Nov;7(11):1062-7
pubmed: 11062564
Nat Immunol. 2018 Sep;19(9):923-931
pubmed: 30104634
J Biol Chem. 1992 Nov 5;267(31):22362-8
pubmed: 1331052
Acta Crystallogr D Struct Biol. 2017 Jun 1;73(Pt 6):522-533
pubmed: 28580914
Nat Methods. 2014 Jan;11(1):63-5
pubmed: 24213166
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):1305-1310
pubmed: 28115689
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Nat Commun. 2016 Apr 25;7:11262
pubmed: 27109927
Sci Rep. 2016 Jun 06;6:27459
pubmed: 27264908
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Elife. 2018 Mar 07;7:
pubmed: 29513216
EMBO J. 2003 Sep 1;22(17):4356-64
pubmed: 12941688
J Mol Biol. 2017 Nov 10;429(22):3500-3524
pubmed: 28583440
Nat Struct Mol Biol. 2009 Feb;16(2):219-25
pubmed: 19169257
EMBO J. 2007 May 2;26(9):2339-49
pubmed: 17431397
J Biol Chem. 1994 Feb 4;269(5):3539-47
pubmed: 8106396
Structure. 2017 Oct 3;25(10):1473-1480.e3
pubmed: 28867616
Science. 1995 Apr 28;268(5210):533-9
pubmed: 7725097
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
Mol Cell Biol. 2006 Apr;26(8):2999-3007
pubmed: 16581775
Trends Biochem Sci. 2014 Jan;39(1):17-24
pubmed: 24286712
Annu Rev Biochem. 2018 Jun 20;87:697-724
pubmed: 29652515
Nature. 2012 Jan 09;481(7381):335-40
pubmed: 22230954
Nat Methods. 2006 Dec;3(12):1021-32
pubmed: 17117155
J Biol Chem. 1992 May 25;267(15):10515-23
pubmed: 1587832
EMBO J. 2002 Jul 1;21(13):3516-25
pubmed: 12093752
Int J Biochem Cell Biol. 2016 Oct;79:437-442
pubmed: 27498189
EMBO Rep. 2018 Oct;19(10):
pubmed: 30104204
Cell Res. 2016 Aug;26(8):869-85
pubmed: 27444871
J Mol Biol. 2005 Mar 11;346(5):1221-7
pubmed: 15713476
J Biol Chem. 1997 Oct 3;272(40):25200-9
pubmed: 9312134
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):E3454-62
pubmed: 23150576
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
EMBO J. 2016 Dec 1;35(23):2602-2613
pubmed: 27789522
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Transl Res. 2018 Aug;198:1-16
pubmed: 29654740
J Biol Chem. 2007 Nov 30;282(48):34869-76
pubmed: 17911101
Nature. 2016 Sep 8;537(7619):229-233
pubmed: 27501246
Nature. 2000 Nov 2;408(6808):115-20
pubmed: 11081519
Curr Med Chem. 2016;23(12):1217-38
pubmed: 26965184
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):12991-12996
pubmed: 27791164
Nat Commun. 2015 Jul 02;6:7573
pubmed: 26133119
Science. 2016 Aug 5;353(6299):594-8
pubmed: 27493187
Nature. 1997 Apr 3;386(6624):463-71
pubmed: 9087403
Cell Mol Life Sci. 2008 Dec;65(24):3971-80
pubmed: 18679578
J Chem Inf Model. 2011 Oct 24;51(10):2778-86
pubmed: 21919503
J Mol Biol. 2001 Oct 26;313(3):465-71
pubmed: 11676531
Cell. 2013 May 23;153(5):1012-24
pubmed: 23706739
Nat Struct Mol Biol. 2007 Dec;14(12):1180-8
pubmed: 18026118
FEBS Lett. 1992 Nov 9;312(2-3):157-60
pubmed: 1426246
Mol Cell. 2010 Mar 12;37(5):728-35
pubmed: 20227375
Nat Rev Mol Cell Biol. 2014 Feb;15(2):122-33
pubmed: 24452470
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):12896-12898
pubmed: 27810957
Cell. 2017 May 18;169(5):792-806
pubmed: 28525752

Auteurs

Ana Toste Rêgo (A)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.

Paula C A da Fonseca (PCA)

MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: pauladf@mrc-lmb.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH